PHARMACOGENOMICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Technology
• Market Snapshot, By Application
• Market Snapshot, By End User
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter’s Analysis

4. Global Pharmacogenomics Market, By Technology, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• DNA Sequencing
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Microarray
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Polymerase Chain Reaction
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Electrophoresis
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Mass Spectrometry
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

5. Global Pharmacogenomics Market, By Application, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Cardiovascular Diseases
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Infectious Diseases
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Oncology
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Neurological Diseases
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Pain Management
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

6. Global Pharmacogenomics Market, By End User, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Hospitals & Clinics
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Research Institutions and Academic Institutes
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Diagnostic Laboratories
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

7. Global Pharmacogenomics Market, By Region, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2021–2033
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Company Profiles
• Thermo Fisher Scientific Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• F. Hoffmann-La Roche Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Pharmigene
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Abbott
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• QIAGEN
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• GE HealthCare
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Empire Genomics, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Bio-Rad Laboratories, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Oxford Nanopore Technologies plc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• PerkinElmer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Myriad Genetics, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Illumina, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Macrogen, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• BGI Genomics
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Eurofins Scientific
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• MapMyGenome
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Invitae Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact